Another case of extended-release bupropion-induced seizure.

نویسنده

  • Douglas Martin Rosoff
چکیده

To the Editor: I read with great interest the report on grand mal seizures being induced by extended-release bupropion hydrochloride (bupropion ER), written by David J. Rissmiller, DO, and Thomas Campo, DO,1 in the October 2007 issue of JAOA—The Journal of the American Osteopathic Association. I too have observed this association between bupropion ER and grand mal seizures. In treating a 42-year-old woman who had been diagnosed with bipolar depression, I prescribed the anticonvulsants lamotrigine (titrated to a final dosage of 200 mg/d) and clonazepam (2 mg/d) over a period of 2 months. Bupropion ER (150 mg/d) was initiated at week 6 and continued for 2 weeks. Upon titration of bupropion ER to 300 mg per day at week 6, the patient experienced a grand mal seizure after 2 days of therapy at the increased dose. All use of bupropion ER was then immediately discontinued. Results of a computed tomographic scan and a lumbar puncture test both proved negative. The patient was then rechallenged within a week with bupropion ER (150 mg/d initially, titrated to 300 mg/d at start of second week). She experienced a second grand mal seizure after 2 days of therapy at the higher dose. The patient had reported no personal history of anorexia nervosa, bulimia, or epilepsy. She had previously been prescribed tramadol hydrochloride (100 mg/d) to relieve chronic shoulder pain, but tramadol had been discontinued 6 weeks prior to her first office visit in the present case. In light of previous reports2-7 that there is a lower incidence of seizures with bupropion ER than with the immediate-release formulation, I feel that the case of my patient and that reported by Drs Rissmiller and Campo1 are clinically important. It is particularly meaningful that the seizures associated with bupropion ER in my patient occurred in conjunction with the use of two anticonvulsants, lamotrigine and clonazepam. I hope that the report by Drs Rissmiller and Campo1 will generate renewed interest in the association between bupropion ER and grand mal seizures.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Extended-release bupropion induced grand mal seizures.

Bupropion hydrochloride is currently available in three formulations: immediate-release, sustained-release, and extended-release (ER). Several published reports exist concerning bupropion's history of inducing seizures in both the immediate- and sustained-release formulations. Although the potential of the ER formulation for causing seizures is noted in the drug's prescribing information, there...

متن کامل

Bupropion attenuates kainic acid-induced seizures and neuronal cell death in rat hippocampus.

Excessive release of glutamate is believed to be a major component of cell damage following excitotoxicity associated with epilepsy. Bupropion, an atypical antidepressant, has been shown to inhibit glutamate release from rat cerebrocortical nerve terminals. The present study was undertaken to investigate whether bupropion has anti-seizure and anti-excitotoxic effects by using a kainic acid (KA)...

متن کامل

Urinary Incontinence during Sleep Associated with Extended Release Form of Bupropion HCI

Bupropion hydrochloride (HCI) is an antidepressant that acts as a norepinephrine and dopamine reuptake inhibitor and has three different dosage forms including immediate release (IR), sustained release (SR), and extended release (ER). Despite its relatively safe side effect profile bupropion may cause several side effects. Here, we aimed to report a case with major depression using extended rel...

متن کامل

Incidence and onset of delayed seizures after overdoses of extended-release bupropion.

BACKGROUND Delayed seizures have been reported with overdoses of bupropion extended-release (XL). This study systematically evaluates the frequency and timing of seizures and an association between other toxic effects (ie, agitation, tremors, and hallucinations) and seizures. METHODS A 3-year multi-poison center observational study of hospitalized patients with ingestion of bupropion XL >or=6...

متن کامل

BUPROPION-INDUCE D CLIMBING THROU GH D -1 AND D-2 DOPAMINE RECEPTOR ACTIVATION

Intraperitoneal (IP) injection of bupropion (3,6, amine (4,16 mg kg•') induced dose-dependent climbing in mice. The climbing response induced by both drugs were decreased in animals pretreated either with the 0-1 antagonist SCH 233<)0 or the 0-2 antagonist sulpiride. The α-adrenoceptor blocker phenoxybenzamine decreased the climbing induced by both bupropion and amphetamine, but the β-ad...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • The Journal of the American Osteopathic Association

دوره 108 4  شماره 

صفحات  -

تاریخ انتشار 2008